MACE-X Announces Patent for Sequential Biological Gating Platform
Transforming Lives Through Biotechnology
Discover the future of precision oncology at MaceX. Our patented platform applies engineering principles and Six Sigma methodology to overcome the root causes of treatment failure—a closed loop biological gated delivery, precision dosing, and real-time measurement to improve therapeutic outcomes. Oncology Reimagined
Revolutionizing Biotechnology
Bioengineering
Our bioengineering expertise enabled us to create and patent a novel First in Class Biological Gated Therapeutics Platform. The entire MACE-X platform is based on verified Scientific data and backed by published peer reviews.